Ellagic acid impedes carbontetrachloride-induced liver damage in rats through suppression of NF-kB, Bcl-2 and regulating Nrf-2 and caspase pathway-Reference-Cited by-同舟云学术

Ellagic acid impedes carbontetrachloride-induced liver damage in rats through suppression of NF-kB, Bcl-2 and regulating Nrf-2 and caspase pathway

Published:2018-09 Issue: Volume:105 Page:662-669
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Aslan Abdullah,Gok Ozlem,Erman Orhan,Kuloglu Tuncay

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference56 articles.

1. Anatomy;Arıncı,2006

2. Suppressive effect of kampo formula “juzen-taiho-to” on carbon tetrachloride-induced hepatotoxicity in mice;Yoshioka;Biol Pharm. Bull.,2016

3. Agaricus blazei murill as an efficient hepatoprotective and antioxidant agent against CCl4-induced liver injury in rats;Al-Dbass;Saudi J. Biol Sci.,2012

4. Hepatoprotective effect of tofu processed from germinated soybean on carbon tetrachloride induced chronic liver injury in mice;Lien;J. Food Health Sci.,2017

5. Protective effects of coriandrum sativum extracts on carbon tetrachloride-induced hepatotoxicity in rats;Sreelatha;Food Chem. Toxicol.,2009

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutathione regulates CIA-activated splenic-lymphocytes via NF-κB/MMP-9 and MAPK/PCNA pathways manipulating immune response;Cellular Immunology;2024-11

2. Ellagic acid supplementation ameliorates cisplatin-induced liver injury in mice by inhibiting the NF-κB pathway and activating the Nrf2/HO-1 pathway;One Health Advances;2024-07-29

3. Bone marrow-derived mesenchymal stem cells reduce CCl ₄ -induced kidney injury and fibrosis in male Wistar rats;Renal Failure;2024-07-25

4. A PRMT5-ZNF326 axis mediates innate immune activation upon replication stress;Science Advances;2024-06-07

5. A Mechanistic Review on Therapeutic Potential of Medicinal Plants and their Pharmacologically Active Molecules for Targeting Metabolic Syndrome;Current Pharmaceutical Design;2024-01